Acer Medical

Acer Medical is a subsidiary of the Acer Group that focuses on the application of artificial intelligence and big data in the healthcare sector. The company specializes in developing AI-assisted diagnostic software, particularly for ophthalmic conditions and chronic disease management. Its flagship product, VeriSee DR, utilizes deep learning to screen for diabetic retinopathy with high accuracy and has received regulatory approvals in multiple jurisdictions. Beyond ophthalmology, Acer Medical is expanding its portfolio to include AI solutions for radiology and cardiovascular health. The company aims to improve clinical efficiency and patient outcomes through the integration of advanced technology into existing medical workflows.